Home › NDC Lookup › RxCUI directory › RxCUI 725094

Progesterone 100 MG Vaginal Insert — RxCUI 725094

Name: Progesterone 100 MG Vaginal Insert (RxCUI 725094)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 725094 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI725094

Official nameProgesterone 100 MG Vaginal Insert

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asprogesterone 100 MG Vaginal Tablet

FDA products mapped4

Package NDCs mapped5

Reported Medicaid activity (SDUD)1,177 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Progesterone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

When you still have your uterus and you're taking estrogen, estrogen can cause the lining of your uterus to grow too thick — a condition called endometrial hyperplasia, which can i...
Why do I need to take progesterone if I'm already on estrogen?
Yes, and it's important to be honest about this. Large studies have shown that taking estrogen combined with progestin — including progesterone — is associated with a higher risk o...
Is it true that taking progesterone with estrogen can raise my risk of breast cancer or stroke?

📖 Read our full Progesterone guide →

🕸️ Concept Web — How Progesterone 100 MG Vaginal Insert Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Progesterone 100 MG Vaginal Insert RxCUI 725094 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Progesterone 8727 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Endometrin 725095 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Progesterone Vaginal Insert 2109022 SCDF
- Progesterone Vaginal Product 1162293 SCDG
- Progesterone Vaginal Insert [Endometrin] 2109024 SBDF
- Endometrin Vaginal Product 1176595 SBDG
- Vaginal Insert 2107950 DF
- Vaginal Product 1151125 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Progesterone 100 MG 317477 SCDC
- Progesterone 100 MG Vaginal Insert [Endometrin] 725098 SBD
- Progesterone 100 MG [Endometrin] 725096 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Progesterone 100 MG SCDC · 317477
Progesterone Vaginal Insert SCDF · 2109022
Progesterone Vaginal Product SCDG · 1162293

Brand-Name Concepts

Progesterone 100 MG Vaginal Insert [Endometrin] SBD · 725098
Progesterone 100 MG [Endometrin] SBDC · 725096
Progesterone Vaginal Insert [Endometrin] SBDF · 2109024
Endometrin Vaginal Product SBDG · 1176595
Endometrin BN · 725095

📦 FDA Products & Package NDCs

4 products · 5 package NDCs

5 package NDCs map to RxCUI 725094 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
55566-6500-03	1 CARTON in 1 CARTON (55566-6500-3) / 21 BLISTER PACK in 1...	ENDOMETRIN	Ferring Pharmaceuticals Inc.	2007-06-21
55566-6500-08	21 CARTON in 1 CARTON (55566-6500-8) / 21 BLISTER PACK in 1...	ENDOMETRIN	Ferring Pharmaceuticals Inc.	2007-06-21
68462-0175-33	21 BLISTER PACK in 1 CARTON (68462-175-33) / 1 INSERT in 1...	PROGESTERONE VAGINAL INSERTS	Glenmark Pharmaceuticals Inc., USA	2026-04-08
70095-0136-03	1 CARTON in 1 CARTON (70095-136-03) / 21 BLISTER PACK in 1...	PROGESTERONE	Sun Pharmaceutical Industries, Inc.	2026-04-27
70700-0201-70	1 CARTON in 1 CARTON (70700-201-70) / 21 BLISTER PACK in 1...	Progesterone vaginal insert	XIROMED, LLC	2025-09-23

Observed labelers: Ferring Pharmaceuticals Inc. (2) · Glenmark Pharmaceuticals Inc., USA (1) · Sun Pharmaceutical Industries, Inc. (1) · XIROMED, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$12.5329

Range $12.5329–$15.1518 · middle 50% $12.5329–$13.8424 · 3 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.